Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

EZZ Life Science Holdings Ltd

Healthcare AU EZZ

1.045AUD
-0.015(1.42%)

Last update at 2026-03-10T23:34:00Z

Day Range

1.041.09
LowHigh

52 Week Range

1.043.35
LowHigh

Fundamentals

  • Previous Close 1.06
  • Market Cap51.28M
  • Volume3716
  • P/E Ratio18.17
  • Dividend Yield1.85%
  • EBITDA10.08M
  • Revenue TTM66.87M
  • Revenue Per Share TTM1.45
  • Gross Profit TTM 49.72M
  • Diluted EPS TTM0.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax 10.59M 9.96M 4.90M 1.78M 2.74M
Minority interest - - - - -
Net income 6.73M 6.96M 3.63M 1.31M 2.03M
Selling general administrative 3.60M 1.26M 1.15M 0.90M 0.68M
Selling and marketing expenses 32.27M 37.23M 20.56M 2.97M 7.84M
Gross profit 49.72M 50.95M 27.20M 7.51M 12.46M
Reconciled depreciation 0.51M 0.39M 0.18M 0.12M 0.13M
Ebit 10.59M 9.98M 4.91M 1.78M 2.75M
Ebitda 11.10M 10.38M 5.09M 1.90M 2.87M
Depreciation and amortization 0.51M 0.39M 0.18M 0.12M 0.13M
Non operating income net other - - - - -
Operating income 9.93M 9.72M 4.62M 1.64M 2.57M
Other operating expenses 56.94M 56.73M 32.53M 13.38M 19.71M
Interest expense 0.03M 0.02M 0.01M 0.00444M 0.01M
Tax provision 3.86M 2.99M 1.27M 0.47M 0.71M
Interest income 0.42M 0.20M 0.24M 0.00037M 0.01M
Net interest income 0.39M 0.17M 0.03M -0.00407M -0.01075M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 3.86M 2.99M 1.27M 0.47M 0.71M
Total revenue 66.87M 66.44M 37.14M 15.02M 22.29M
Total operating expenses 39.79M 41.23M 22.59M 5.87M 9.89M
Cost of revenue 17.15M 15.50M 9.94M 7.51M 9.83M
Total other income expense net 0.66M 0.24M 0.29M 0.14M 0.16M
Discontinued operations - - - - -
Net income from continuing ops 6.73M 6.96M 3.63M 1.31M 2.03M
Net income applicable to common shares 6.73M 6.96M 3.63M 1.31M 2.03M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 33.96M 25.55M 17.64M 14.27M 12.04M
Intangible assets 0.03M - 0.02M 0.02M 0.01M
Earning assets - - - - -
Other current assets 0.89M 1.81M 0.94M 0.90M 0.42M
Total liab 5.87M 4.23M 3.06M 2.88M 1.93M
Total stockholder equity 28.09M 21.32M 14.58M 11.39M 10.11M
Deferred long term liab - - - - -
Other current liab - 0.04M 0.36M 0.32M 0.26M
Common stock - 6.52M 6.00M 5.82M 5.67M
Capital stock 8.74M - 6.00M 5.82M 5.67M
Retained earnings 19.32M 14.79M 8.58M 5.56M 4.44M
Other liab - - - 0.06M 0.00133M
Good will - - - - -
Other assets - - 0.01M 0.13M 0.16M
Cash 20.85M 19.02M 13.83M 10.46M 8.85M
Cash and equivalents - - - - -
Total current liabilities 5.73M 4.18M 2.93M 2.82M 1.93M
Current deferred revenue - 1.20M - - -
Net debt - -18.89876M - -10.36027M -8.77463M
Short term debt - 0.12M 0.00000M 0.10M 0.08M
Short long term debt - - - - -
Short long term debt total - 0.12M - 0.10M 0.08M
Other stockholder equity - 0.00000M 0.00081M - -
Property plant equipment - - 0.60M 0.15M 0.13M
Total current assets 33.04M 24.91M 17.01M 13.97M 11.73M
Long term investments - - - - -
Net tangible assets - - 14.56M 11.37M 10.10M
Short term investments - - - - -
Net receivables 4.47M 2.67M 1.39M 2.29M 2.19M
Long term debt - - - - -
Inventory 2.43M 1.40M 0.85M 0.31M 0.27M
Accounts payable 3.46M 2.82M 2.14M 2.39M 1.59M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.02M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.02M - - -
Deferred long term asset charges - - - - -
Non current assets total 0.92M 0.64M 0.63M 0.29M 0.30M
Capital lease obligations 0.30M - 0.48M 0.10M 0.08M
Long term debt total - - 0.12M 0.00000M 0.00000M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -0.54693M -0.44117M -0.10179M -0.01318M -0.01612M
Change to liabilities - - -0.16386M 0.88M -1.71869M
Total cashflows from investing activities -0.54693M -0.44117M -0.10179M -0.01318M -0.01612M
Net borrowings - - -0.16132M -0.10419M -0.10726M
Total cash from financing activities -2.17177M -0.58245M -0.76172M -0.27736M 5.44M
Change to operating activities - - -0.01565M -0.47738M -0.06108M
Net income 6.73M 6.96M 3.63M 1.31M 2.03M
Change in cash 1.83M 5.19M 3.37M 1.61M 5.68M
Begin period cash flow 19.02M 13.83M 10.46M 8.85M 3.17M
End period cash flow 20.85M 19.02M 13.83M 10.46M 8.85M
Total cash from operating activities 4.35M 6.14M 4.01M 1.90M 0.25M
Issuance of capital stock - 0.85M - - 6.00M
Depreciation - 0.39M 0.18M 0.12M 0.13M
Other cashflows from investing activities -0.30283M -0.03188M - -0.00750M -0.01015M
Dividends paid 1.82M 1.08M 0.60M 0.17M 0.11M
Change to inventory -1.03160M -0.55428M -0.53452M -0.04079M -0.23880M
Change to account receivables -1.83792M -1.28600M 0.91M -0.10503M 0.35M
Sale purchase of stock - - - 0.00000M -0.44984M
Other cashflows from financing activities 0.00000M -0.35474M -0.16132M -0.10419M -0.10726M
Change to netincome - - -0.03927M 0.16M 0.00149M
Capital expenditures 0.26M 0.41M 0.10M 0.01M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -4.57786M -1.15590M 0.24M 0.31M -1.90409M
Stock based compensation - 0.02M 0.18M 0.16M -
Other non cash items 8.93M -0.05628M 0.17M -0.23994M 0.00150M
Free cash flow 4.09M 5.73M 3.91M -0.01318M 0.24M

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EZZ
EZZ Life Science Holdings Ltd		 -0.015 1.42% 1.04 18.17 - 0.77 2.12 0.74 7.13
CSL
CSL Ltd		 -2.2 1.52% 142.36 16.70 19.49 4.61 2.68 3.87 11.63
TLX
TELIX Pharmaceuticals Ltd		 0.10 0.91% 11.10 - 1000.00 4.25 5.68 3.34 76.39
MSB
Mesoblast Ltd		 0.03 1.15% 2.21 - 454.55 43.02 3.19 28.08 -9.8623
NEU
Neuren Pharmaceuticals Ltd		 -0.1 0.78% 12.65 53.70 45.66 24.19 4.61 19.56 57.40

Reports Covered

Stock Research & News

View All

Profile

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.

EZZ Life Science Holdings Ltd

Shop 1, 55-59 Parramatta Road, Lidcombe, NSW, Australia, 2141

Key Executives

Name Title Year Born
Mr. Mark Qin Co-founder, COO, Interim CEO & Exec. Director NA
Anthony Guarna Chief Financial Officer NA
Ms. Natalie Climo L.L.B. Company Sec. NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.